<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://psiconautica.org/noticias/texas-ensayos-clinicos-ibogaina-impact/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-22T11:56:35+02:00</news:publication_date>
      <news:title>Texas arranca sus propios ensayos clínicos con ibogaína tras no encontrar farmacéutica</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/juicio-muerte-retiro-psicodelico-miami-beach/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-22T11:16:36+02:00</news:publication_date>
      <news:title>A juicio la muerte de una mujer en un retiro psicodélico sin garantías de Miami Beach</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/psilocibina-estudio-real-zurich-depresion-resistente/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-22T11:11:59+02:00</news:publication_date>
      <news:title>Zúrich publica el primer estudio real del uso clínico de psilocibina</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/5-meo-dmt-inhalado-depresion-posparto/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-22T10:32:00+02:00</news:publication_date>
      <news:title>Una dosis inhalada de 5-MeO-DMT revierte la depresión posparto en horas</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/patron-cerebral-comun-lsd-psicodelicos-nature-medicine/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-22T09:52:01+02:00</news:publication_date>
      <news:title>El mayor mapeo cerebral de psicodélicos revela el patrón común del LSD</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/pueblo-dine-pide-dea-excluya-mescalina-permiso-farmaceutico/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-22T09:12:01+02:00</news:publication_date>
      <news:title>El pueblo dine pide a la DEA que excluya la mescalina de un permiso</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/nexus-2026-consciencia-arte-libertad/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-21T12:48:01+02:00</news:publication_date>
      <news:title>Nexus 2026: consciencia, arte y libertad en los márgenes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/psilocibina-migrana-ensayo-piloto-yale-2026/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-21T11:49:11+02:00</news:publication_date>
      <news:title>Psilocibina para la migraña: respuesta del 80% en un ensayo piloto de Yale</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/ketamina-receptores-ampa-depresion-resistente-estudio-pet/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-21T11:09:11+02:00</news:publication_date>
      <news:title>La ketamina repara circuitos cerebrales en la depresión resistente</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/eli-lilly-compra-ataibeckley-5-meo-dmt-depresion-resistente/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-21T10:29:12+02:00</news:publication_date>
      <news:title>Eli Lilly compra por 3.800 millones el spray nasal de 5-MeO-DMT</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/oregon-duplicar-tasas-programa-psilocibina/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-21T09:49:13+02:00</news:publication_date>
      <news:title>Oregón plantea duplicar las tasas de su programa legal de psilocibina</news:title>
    </news:news>
  </url>
</urlset>